Altay Therapeutics
PrivateLast Round
Grant
Sep 1, 2023
Est. Valuation
$2.14M
Total Funding Raised
$3.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Altay Therapeutics is a biotechnology company that develops small molecule therapeutics targeting transcription factors to treat chronic inflammatory diseases, neuromuscular disorders, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altay Therapeutics Comparables
Compare Altay Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myocea, Inc. | 81% | |
| Fulcrum Therapeutics, Inc. | 79% | |
| TippingPoint Biosciences | 79% |
Altay Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Grant | Jul 11, 2023 | ||||
| Seed | Sep 21, 2022 | ||||
| Accelerator | Mar 16, 2020 |
Key People
Founding team and executive leadership
Altay Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Solve FSHD | Grant, Seed |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 551% MoM, reaching 1.4K.
- May 16, 2026
Monthly visitors increased 59% MoM.
Altay Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Altay Therapeutics's valuation, stock price, and market status.
Is Altay Therapeutics a public or private company?
Altay Therapeutics is a private company.
What is the current stock price of Altay Therapeutics?
Altay Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Altay Therapeutics worth (valuation)?
Valuation information for Altay Therapeutics is not publicly available.
Can I buy Altay Therapeutics stock?
Altay Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Altay Therapeutics's last funding round?
Altay Therapeutics's most recent funding round was Grant on September 1, 2023.
Who are the main investors in Altay Therapeutics?
Key investors in Altay Therapeutics include Solve FSHD.
Will Altay Therapeutics IPO soon?
No public IPO plans have been announced for Altay Therapeutics.
How can I track Altay Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altay Therapeutics's secondary market activity and sign up for updates.